VISTN logo

Vistin Pharma ASA Stock Price

OB:VISTN Community·NOK 904.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

VISTN Share Price Performance

NOK 20.40
-3.50 (-14.64%)
NOK 20.40
-3.50 (-14.64%)
Price NOK 20.40

VISTN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

2 Risks
2 Rewards

Vistin Pharma ASA Key Details

NOK 455.2m

Revenue

NOK 152.8m

Cost of Revenue

NOK 302.4m

Gross Profit

NOK 224.4m

Other Expenses

NOK 78.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 12, 2026
1.76
66.43%
17.15%
6.7%
View Full Analysis

About VISTN

Founded
1969
Employees
73
CEO
Magnus Tolleshaug
WebsiteView website
www.vistin.com

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

Recent VISTN News & Updates

Recent updates

No updates